Jill A. Howe - 10 Mar 2025 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Chief Financial Officer
Signature
/s/ Jill A. Howe
Issuer symbol
LCTX
Transactions as of
10 Mar 2025
Net transactions value
$0
Form type
4
Filing time
12 Mar 2025, 17:30:36 UTC
Previous filing
26 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Employee Stock Option (Right to Buy) Award $0 +750,000 $0.000000 750,000 10 Mar 2025 Common Shares 750,000 $0.5300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.